These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10699300)

  • 1. The preparation and evaluation of poly(epsilon-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug.
    Hombreiro Pérez M; Zinutti C; Lamprecht A; Ubrich N; Astier A; Hoffman M; Bodmeier R; Maincent P
    J Control Release; 2000 Apr; 65(3):429-38. PubMed ID: 10699300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable microparticles as a two-drug controlled release formulation: a potential treatment of inflammatory bowel disease.
    Lamprecht A; Rodero Torres H; Schäfer U; Lehr CM
    J Control Release; 2000 Dec; 69(3):445-54. PubMed ID: 11102684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly (epsilon-caprolactone) microparticles containing Levobunolol HCl prepared by a multiple emulsion (W/O/W) solvent evaporation technique: effects of some formulation parameters on microparticle characteristics.
    Karataş A; Sonakin O; Kiliçarslan M; Baykara T
    J Microencapsul; 2009 Feb; 26(1):63-74. PubMed ID: 18608798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of crystalline microstructure on drug release behavior of poly(epsilon-caprolactone) microspheres.
    Jeong JC; Lee J; Cho K
    J Control Release; 2003 Oct; 92(3):249-58. PubMed ID: 14568406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of propranolol hydrochloride nanoparticles: a comparative study.
    Ubrich N; Bouillot P; Pellerin C; Hoffman M; Maincent P
    J Control Release; 2004 Jun; 97(2):291-300. PubMed ID: 15196756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-degradable microparticles containing a hydrophilic and/or a lipophilic drug: preparation, characterization and drug release modeling.
    Hombreiro-Pérez M; Siepmann J; Zinutti C; Lamprecht A; Ubrich N; Hoffman M; Bodmeier R; Maincent P
    J Control Release; 2003 Mar; 88(3):413-28. PubMed ID: 12644367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disodium norcantharidate loaded poly(epsilon-caprolactone) microspheres I. Preparation and evaluation.
    Wang S; Guo S; Cheng L
    Int J Pharm; 2008 Feb; 350(1-2):130-7. PubMed ID: 17900833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterizations, in vitro and in vivo evaluation of Etoricoxib-loaded Poly (Caprolactone) microparticles--a potential Intra-articular drug delivery system for the treatment of Osteoarthritis.
    Arunkumar P; Indulekha S; Vijayalakshmi S; Srivastava R
    J Biomater Sci Polym Ed; 2016; 27(4):303-16. PubMed ID: 26689653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nifedipine molecular dispersion in microparticles of ammonio methacrylate copolymer and ethylcellulose binary blends for controlled drug delivery: effect of matrix composition.
    Huang J; Wigent RJ; Schwartz JB
    Drug Dev Ind Pharm; 2006; 32(10):1185-97. PubMed ID: 17090441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of polymer blends on the characterization of gliclazide--encapsulated into poly (ε-caprolactone) microparticles.
    Barakat NS; Shazly GA; Almedany AH
    Drug Dev Ind Pharm; 2013 Feb; 39(2):352-62. PubMed ID: 22540378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
    Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
    Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encapsulation of water-soluble drugs by an o/o/o-solvent extraction microencapsulation method.
    Elkharraz K; Ahmed AR; Dashevsky A; Bodmeier R
    Int J Pharm; 2011 May; 409(1-2):89-95. PubMed ID: 21356287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of novel poly(sebacic anhydride-co-Pluronic F68/F127) biopolymeric microspheres for the controlled release of nifedipine.
    Shelke NB; Aminabhavi TM
    Int J Pharm; 2007 Dec; 345(1-2):51-8. PubMed ID: 17616283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
    Xu H; Zhong H; Liu M; Xu C; Gao Y
    Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adapalene-loaded poly(ε-caprolactone) microparticles: Physicochemical characterization and in vitro penetration by photoacoustic spectroscopy.
    Nadal JM; Dos Anjos Camargo G; Novatski A; Macenhan WR; Dias DT; Barboza FM; Lyra A; Roik JR; Padilha de Paula J; Somer A; Farago PV
    PLoS One; 2019; 14(3):e0213625. PubMed ID: 30897170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Full factorial design optimization of anti-inflammatory drug release by PCL-PEG-PCL microspheres.
    Azouz L; Dahmoune F; Rezgui F; G'Sell C
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():412-9. PubMed ID: 26478328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, characterization and in vitro release properties of ibuprofen-loaded microspheres based on polylactide, poly(epsilon-caprolactone) and their copolymers.
    Zhu KJ; Li Y; Jiang HL; Yasuda H; Ichimaru A; Yamamoto K; Lecomte P; Jerome R
    J Microencapsul; 2005 Feb; 22(1):25-36. PubMed ID: 16019888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the microencapsulation of nanoparticles on the reduction of burst release.
    Hasan AS; Socha M; Lamprecht A; Ghazouani FE; Sapin A; Hoffman M; Maincent P; Ubrich N
    Int J Pharm; 2007 Nov; 344(1-2):53-61. PubMed ID: 17643878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan and poly(methyl vinyl ether-co-maleic anhydride) microparticles as nasal sustained delivery systems.
    Cerchiara T; Luppi B; Chidichimo G; Bigucci F; Zecchi V
    Eur J Pharm Biopharm; 2005 Oct; 61(3):195-200. PubMed ID: 16006107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of 3,4-diaminopyridine microparticles by solvent-evaporation methods.
    Gibaud S; Bonneville A; Astier A
    Int J Pharm; 2002 Aug; 242(1-2):197-201. PubMed ID: 12176246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.